143 related articles for article (PubMed ID: 29530992)
1. A Cumulative Analysis of Current Evidence for Association between Expression of Epithelial-Mesenchymal Transition Markers and Clinicopathological Outcomes in Patients after Radical Prostatectomy.
Jiang G; Hu Q; Wang H; Ding W; Zhang N; Wu Y; Zhou Q; Sun C; Xia G; Ding Q; Na R; Xu K
Ann Clin Lab Sci; 2018 Jan; 48(1):18-28. PubMed ID: 29530992
[TBL] [Abstract][Full Text] [Related]
2. Expression patterns of epithelial-mesenchymal transition markers in localized prostate cancer: significance in clinicopathological outcomes following radical prostatectomy.
Behnsawy HM; Miyake H; Harada K; Fujisawa M
BJU Int; 2013 Jan; 111(1):30-7. PubMed ID: 23107154
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-Mesenchymal Transition Markers β-catenin, Snail, and E-Cadherin do not Predict Disease Free Survival in Prostate Adenocarcinoma: a Prospective Study.
Ipekci T; Ozden F; Unal B; Saygin C; Uzunaslan D; Ates E
Pathol Oncol Res; 2015 Sep; 21(4):1209-16. PubMed ID: 26037169
[TBL] [Abstract][Full Text] [Related]
4. Akt Activation Correlates with Snail Expression and Potentially Determines the Recurrence of Prostate Cancer in Patients at Stage T2 after a Radical Prostatectomy.
Chen WY; Hua KT; Lee WJ; Lin YW; Liu YN; Chen CL; Wen YC; Chien MH
Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27455254
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of epithelial-mesenchymal transition markers in prostate cancer.
Figiel S; Vasseur C; Bruyere F; Rozet F; Maheo K; Fromont G
Hum Pathol; 2017 Mar; 61():26-32. PubMed ID: 27818287
[TBL] [Abstract][Full Text] [Related]
6. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.
Yamada S; Okumura N; Wei L; Fuchs BC; Fujii T; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y
Ann Surg Oncol; 2014 Nov; 21(12):3882-90. PubMed ID: 24833103
[TBL] [Abstract][Full Text] [Related]
7. Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy.
Harada K; Miyake H; Kusuda Y; Fujisawa M
BJU Int; 2012 Dec; 110(11 Pt C):E1131-7. PubMed ID: 22712620
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of epithelial-mesenchymal transition markers in localized prostate cancer: significance in clinicopathological outcomes following radical prostatectomy.
Matuszak EA; Kyprianou N
BJU Int; 2013 Jan; 111(1):6-7. PubMed ID: 23107294
[No Abstract] [Full Text] [Related]
9. The epithelial-mesenchymal transition regulators Twist, Slug, and Snail are associated with aggressive tumour features and poor outcome in prostate cancer patients.
Børretzen A; Gravdal K; Haukaas SA; Mannelqvist M; Beisland C; Akslen LA; Halvorsen OJ
J Pathol Clin Res; 2021 May; 7(3):253-270. PubMed ID: 33605548
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C
Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876
[TBL] [Abstract][Full Text] [Related]
11. TWIST overexpression predicts biochemical recurrence-free survival in prostate cancer patients treated with radical prostatectomy.
Raatikainen S; Aaltomaa S; Palvimo JJ; Kärjä V; Soini Y
Scand J Urol; 2015 Feb; 49(1):51-7. PubMed ID: 24779451
[TBL] [Abstract][Full Text] [Related]
12. Expression profile of epithelial-mesenchymal transition markers in non-muscle-invasive urothelial carcinoma of the bladder: correlation with intravesical recurrence following transurethral resection.
Liu B; Miyake H; Nishikawa M; Fujisawa M
Urol Oncol; 2015 Mar; 33(3):110.e11-8. PubMed ID: 25262382
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer.
Katz B; Reis ST; Viana NI; Morais DR; Moura CM; Dip N; Silva IA; Iscaife A; Srougi M; Leite KR
PLoS One; 2014; 9(11):e113700. PubMed ID: 25409297
[TBL] [Abstract][Full Text] [Related]
14. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
15. Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer.
Kolijn K; Verhoef EI; van Leenders GJ
Oncotarget; 2015 Sep; 6(27):24488-98. PubMed ID: 26041890
[TBL] [Abstract][Full Text] [Related]
16. Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression.
Jørgensen CLT; Forsare C; Bendahl PO; Falck AK; Fernö M; Lövgren K; Aaltonen K; Rydén L
Breast Cancer Res Treat; 2020 Jun; 181(2):369-381. PubMed ID: 32300922
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.
Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M
Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of the genetic and the immunohistochemical expression of epithelial-mesenchymal-related markers in colon cancer.
Rashed HE; Hussein S; Mosaad H; Abdelwahab MM; Abdelhamid MI; Mohamed SY; Mohamed AM; Fayed A
Cancer Biomark; 2017 Jul; 20(1):107-122. PubMed ID: 28759954
[TBL] [Abstract][Full Text] [Related]
19. Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer.
Benko G; Spajić B; Krušlin B; Tomas D
Urol Oncol; 2013 May; 31(4):468-74. PubMed ID: 21514185
[TBL] [Abstract][Full Text] [Related]
20. Lamin A/C might be involved in the EMT signalling pathway.
Zuo L; Zhao H; Yang R; Wang L; Ma H; Xu X; Zhou P; Kong L
Gene; 2018 Jul; 663():51-64. PubMed ID: 29665450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]